New scope test could sharpen lung cancer staging, spare patients unnecessary radiation
NCT ID NCT01786590
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a minimally invasive procedure called EBUS-TBNA is more accurate than standard CT/PET scans for checking if lung cancer has spread to lymph nodes in the chest. The goal is to better select patients for a precise type of radiation therapy (SBRT). About 150 adults with early-stage non-small cell lung cancer who cannot have surgery will undergo EBUS-TBNA before their radiation treatment. The results could help doctors make more informed treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- EBUS-TBNA (a minimally invasive procedure using a thin, flexible tube with an ultrasound probe to sample lymph nodes)
- What this could lead to
- If EBUS-TBNA proves more accurate than CT/PET scans, it could help doctors better decide who is eligible for SBRT, potentially improving outcomes for patients who cannot have surgery.
- What could go wrong
- This is a diagnostic accuracy study, not a treatment trial. Even if EBUS-TBNA is more accurate, it may not directly improve survival or quality of life. The procedure itself carries small risks like bleeding or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Toronto General Hospital
RECRUITINGToronto, Ontario, M5G 1L7, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?